3//SEC Filing
KDev Investments AB 3
Accession 0001123292-19-001194
CIK 0001781983other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 8:50 PM ET
Size
32.7 KB
Accession
0001123292-19-001194
Insider Transaction Report
Form 3
KDev Investments AB
10% Owner
Holdings
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (590,445 underlying) - 844,278(indirect: See Footnote)
Common Stock
- (indirect: See footnote)
Series A Convertible Preferred Stock
→ Common Stock (579,647 underlying) - (indirect: See footnote)
Series C Convertible Preferred Stock
→ Common Stock (430,467 underlying)
Karolinska Development AB
10% Owner
Holdings
- 844,278(indirect: See Footnote)
Common Stock
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (590,445 underlying) - (indirect: See footnote)
Series A Convertible Preferred Stock
→ Common Stock (579,647 underlying) - (indirect: See footnote)
Series C Convertible Preferred Stock
→ Common Stock (430,467 underlying)
KCIF Co-Investment Fund KB
10% Owner
Holdings
- (indirect: See footnote)
Series A Convertible Preferred Stock
→ Common Stock (579,647 underlying) - (indirect: See footnote)
Series C Convertible Preferred Stock
→ Common Stock (430,467 underlying) - 844,278(indirect: See Footnote)
Common Stock
- (indirect: See footnote)
Series B Convertible Preferred Stock
→ Common Stock (590,445 underlying)
Footnotes (3)
- [F1]See Exhibit 99.1
- [F2]See Exhibit 99.1
- [F3]See Exhibit 99.1
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
IncorporatedSweden
Related Parties
1- filerCIK 0001789888
Filing Metadata
- Form type
- 3
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 8:50 PM ET
- Size
- 32.7 KB